Do you have
expertise
in
complex
clinical study start-
up
, and passion for accelerating site activations to bring life-changing medicines to patients? Would you like to apply your end-to-end start-up and contracts
expertise
in a company that follows the science and turns ideas into medicines? Then AstraZeneca might be the one for you!
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas – Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory & Immunology (R&I); and Rare Disease. At AstraZeneca Australia, we have been working to deliver the best value to patients for more than 60 years, and we push the boundaries of science to deliver life-changing medicines. What you’ll do Y ou will lead end-to-end start- up of oncology study sites , with responsibility for eth ics and regulatory submissions as well as site-level contract and budget negotiations to enable timely , compliant activation. You’ll work cross-functionally internally and directly with sites, and report to the Oncology Study Start U p Associate Director . This full time 12 month contract role is based in Sydney with hybrid working (in the office 3 days/week).